Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties

[Image: see text] Largazole is a potent and class I-selective histone deacetylase (HDAC) inhibitor purified from marine cyanobacteria and was demonstrated to possess antitumor activity. Largazole employs a unique prodrug strategy, via a thioester moiety, to liberate the bioactive species largazole t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Salvador, Lilibeth A., Park, Heekwang, Al-Awadhi, Fatma H., Liu, Yanxia, Kim, Bumki, Zeller, Sabrina L., Chen, Qi-Yin, Hong, Jiyong, Luesch, Hendrik
פורמט: Artigo
שפה:Inglês
יצא לאור: American Chemical Society 2014
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4137384/
https://ncbi.nlm.nih.gov/pubmed/25147612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml500170r
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים